Overview
Status
Active
Registry date
2013-02-08
Share capital
505,000.00 PLN
Financials
Revenue history (in k)
Filing timeliness
3 of 6 financial statements were filed late (the longest delay 181 days for 2024), 2 not filed.
- 202521/08/2026
- 202412/01/2026
- 2023not filed
- 2022not filed
- 202111/10/2022
- 202030/09/2021
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Revenue
This companyUSD 0.12MedianUSD 1.07mAverageUSD 22.38m
Net profit
This companyUSD -204.43MedianUSD 37.33kAverageUSD 879.18k
Operating costs
This companyUSD 204.43MedianUSD 926.31kAverageUSD 21.06m
Assets
This companyUSD 235.26kMedianUSD 609.81kAverageUSD 11.84m
Industry
Authorized Representatives
Michał Burzykowski – President of the Management Board
Manner of representation
Each member of the management board has the right to represent the company independently
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Marek Krawczykage 64 | 9,600 | $129,659.64 | 95.0495% |
| 500 | $6,753.11 | 4.9505% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2013-03-01.
36 1160 2202 0000 0005 8424 0274
74 1160 2202 0000 0005 8424 0269
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
| BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Optimedussp. z o.o. | $1.00 | optimedus.pl | ||
| Auditustechsp. z o.o. | $0.60 | auditustech.com | ||
| Prime Next Generationsp. z o.o. | $0.31 | prime-next-generation.pl | ||
| Amarox Pharmasp. z o.o. | $0.31 | amaroxpharma.pl | ||
| ITER Pharmasp. z o.o. | $0.17 | iterpharma.pl | ||
| Novaovasp. z o.o. | $0.16 | novaova.pl | ||
| Revital Medicasp. z o.o. | $0.10 | revitalmedica.com.pl | ||
| Astra Innovasp. z o.o. | $0.09 | astrainnova.eu | ||
| Euro Eco Foodsp. z o.o. | $0.07 | euroecofood.pl | ||
| Forcleversp. z o.o. | $0.04 | forclever.pl |
Change history
| Date | Event | |
|---|---|---|
| 2023-04-03 | Address change (Ul. Marszałkowska 58, 00-545, Warszawa → Aleje Jerozolimskie 89/43, 02-001, Warszawa) | |
| 2017-06-14 | Address change (Piękna 20, 00-549, Warszawa → Ul. Marszałkowska 58, 00-545, Warszawa) | |
| 2017-06-14 | PKD change (Removed: 61 codes) | |
| 2014-09-29 | Name change (Quantum Of Development → Medco Pharma) | |
| 2014-09-29 | PKD change (Removed: 64 codes; Added: 64 codes) |
FAQ
The main business activity of Medco Pharma focuses on wholesale of pharmaceutical goods.
The company was registered in the Polish National Court Register (KRS) on February 8, 2013.
The headquarters is located at: Aleje Jerozolimskie 89, 02-001 Warszawa.
The share capital of the company is PLN 505,000 (approx. $136,413).
The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.
The company reported a revenue of USD 0 in 2025.
No, in 2025 the company was not profitable, reporting a net loss of USD 204. For comparison, in 2024 the loss was USD 5,579, meaning the company reduced its loss by 96.3%.
The largest operating cost category falls under other operating costs. This category amounted to USD 144 in 2025, representing 71% of all operating expenses.
Last updated: 2026-10-28